ASX Share rice
Mon 17 May 2021 - 11:26:am (Sydney)

VBS Share Price

VECTUS BIOSYSTEMS LIMITEDVBSPharmaceuticals, Biotechnology & Life Sciences

VBS Company Information

Name:

Vectus Biosystems Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

3-11 Primrose Avenue Rosebery NSW Australia 2018

Phone:

61 2 9662 4144

CEO & Exec. Director:

Dr. Karen Annette Duggan

Company Sec.:

Mr. Robert John Waring BEc, CA, FCIS, FFin, FAICD

Consultant:

Prof. Graham Jon MacDonald AM, M.D., BSc (Med), BS, FRACP, FRCP, FANZCC

Company Overview:

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure. Its lead compound is VB0004, which has potent anti-hypertensive properties, as well as anti-fibrotic activity in the heart and kidneys. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that improves speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was founded in 2005 and is based in Rosebery, Australia.

VBS Share Price Information

Shares Issued:

31.66M

Market Capitalisation:

$30.39M

Revenue (TTM):

$101.26K

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.068

Operating Margin (TTM):

$-30.27

Return On Assets (TTM):

$-0.30

Quarterly Revenue Growth (YOY):

229.697

Gross Profit(TTM):

$51.19K

Diluted Earnings Per Share (TTM):

$-0.17

VBS CashFlow Statement

CashFlow Date:

2020-06-30

Change To Liabilities:

$-532,528

Net Borrowings:

$5.96M

Net Income:

$-2,996,071

Total Cash From Operating Activities:

$-3,001,547

Depreciation:

$19.52K

Capital Expenditures:

$0

VBS Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-3,379,700

Net Income:

$-2,996,070

Operating Income:

$-2,663,360

Interest Expense:

$716.34K

Income Tax Expense:

$-383,629

Total Revenue:

$51.19K

VBS Balance Sheet

Balance Sheet Date:

2020-06-30

Total Liabilities:

$8.64M

Total Stockholder Equity:

$-5,644,610

Other Current Liabilities:

$15.20K

Total Assets:

$3M

Common Stock:

$17.86M

Other Current Assets:

$203.25K

Retained Earnings:

$-24,842,922

Other Liabilities:

$340

Cash:

$2.69M

Total Current Liabilities:

$1.45M

Property - Plant & Equipment:

$78.71K

Net Tangible Assets:

$-5,644,613

Total Current Assets:

$2.92M

Long-Term Debt:

$7.16M

Net Receivables:

$78.65K

Short-Term Investments:

$78.71K

Accounts Payable:

$606.20K

Short-Term Investments:

$78.71

Non Current Liabilities Total:

$7.20M

VBS Share Price History

VBS News

01 Oct, 2020
The CEO of Vectus Biosystems Limited (ASX:VBS) is Karen Duggan, and this article examines the executive's compensation...